The European Commission has today welcomed the adoption by EU Member States of an international agreement which will make it easier to trade in pharmaceuticals. The third revision of the Pharma-GATT Agreement will eliminate customs duties among the main pharmaceutical trading nations and territories and will improve the competitiveness of the EU pharmaceutical companies. Over the last few years, the European Commission assumed a leading role in the negotiations towards the conclusion of this Agreement and its revision. [European Commission Press Release]